EORTC characterizes responders and survivors on pazopanib for advanced soft tissue sarcoma
An EORTC analysis appearing in Annals of Oncology confirmed the importance of known prognostic factors such as performance status and tumor grading for having a long-term outcome in patients treated with pazopanib for metastatic ...
Feb 10, 2014
0
0